Castle Biosciences — Fact Sheet (November 2025)

2 slides from Castle Biosciences's fact sheet, Nov 3, 2025

Slide 1: Q3 2025 Fact Sheet
Q3 2025 FACT SHEET Empowering people, informing care decisions Q3 2025 Review delivered in As of September 30, 2025, cash, cash equivalents $287.5 1. The Novitas local coverage determination, or LCD, that included non-coverage language for DecisionDx-SCC, went into effect on April 24, 2025 96,071 28
Slide 2: Financial Information; Non-GAAP Financial Measures
Financial Information; Non-GAAP Financial Measures to the historical accounting valuations of intangible assets, which are applicable only to tests we acquired rather than internally developed. However, these non-GAAP financial The table below presents the reconciliation of Adjusted Revenues and Adj